Giulia Casorati

10.1k total citations · 2 hit papers
131 papers, 7.4k citations indexed

About

Giulia Casorati is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Giulia Casorati has authored 131 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Immunology, 45 papers in Oncology and 26 papers in Molecular Biology. Recurrent topics in Giulia Casorati's work include Immune Cell Function and Interaction (80 papers), T-cell and B-cell Immunology (70 papers) and Immunotherapy and Immune Responses (43 papers). Giulia Casorati is often cited by papers focused on Immune Cell Function and Interaction (80 papers), T-cell and B-cell Immunology (70 papers) and Immunotherapy and Immune Responses (43 papers). Giulia Casorati collaborates with scholars based in Italy, United States and Switzerland. Giulia Casorati's co-authors include Paolo Dellabona, Antonio Lanzavecchia, Elisabetta Padovan, Manfred Brockhaus, Nicola Migone, Claudia de Lalla, Sergio Abrignani, Yasuhiko Koezuka, Gennaro De Libero and Mitchell Kronenberg and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Giulia Casorati

130 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene Therapy in Peripheral Blood Lymphocytes and Bone Marrow for ADA ⁻ Immunodeficient Patients

1995 632 citations Giulia Casorati, Paola Panina‐Bordignon et al. profile →
CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution

1998 555 citations Giulia Casorati, Paolo Dellabona et al. profile →

Peers

Countries citing papers authored by Giulia Casorati

Since Specialization

Citations

This map shows the geographic impact of Giulia Casorati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Casorati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Casorati more than expected).

Fields of papers citing papers by Giulia Casorati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Casorati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Casorati. The network helps show where Giulia Casorati may publish in the future.

Co-authorship network of co-authors of Giulia Casorati

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Casorati. A scholar is included among the top collaborators of Giulia Casorati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Casorati. Giulia Casorati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Highlighting recent achievements to advance more effective cancer immunotherapy 2025 ·Journal of Experimental & Clinical Cancer Research ·Beatrice Belmonte, Sheila Spada, Paola Allavena, Matteo Benelli, Vincenzo Bronte, Giulia Casorati, Lorenzo D’Ambrosio, Roberto Ferrara, Anna Mondino, Paola Nisticò, Roberta Sommaggio, Marcella Tazzari, Claudio Tripodo, Antonio Sica, Pier Francesco Ferrucci	1
2	Genomic binding of NF-Y in mouse and human cells 2024 ·Genomics ·(unknown), Andrea Bernardini, (unknown), Michele Ceribelli, Giacomo Donati, (unknown), Giulio Pavesi, Paolo Dellabona, Giulia Casorati, Graziella Messina, Roberto Mantovani, Diletta Dolfini	3
3	CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms 2024 ·Nature Cancer ·Xin Zhou, Ying Wang, Zhangqi Dou, Gloria Delfanti, (unknown), (unknown), (unknown), (unknown), Mark G. Woodcock, Giulia Casorati, Paolo Dellabona, William Y. Kim, Linjie Guo, Barbara Savoldo, Ageliki Tsagaratou, J. Justin Milner, Leonid S. Metelitsa, Gianpietro Dotti	21
4	IL-12 reprograms CAR-expressing natural killer T cells to long-lived Th1-polarized cells with potent antitumor activity 2024 ·Nature Communications ·Elisa Landoni, Mark G. Woodcock, Gabriel A. Barragán, (unknown), (unknown), (unknown), Leah M. Flick, (unknown), (unknown), Giulia Casorati, Paolo Dellabona, Pietro Genovese, Barbara Savoldo, Leonid S. Metelitsa, Gianpietro Dotti	30
5	Preexisting Immunity Drives the Response to Neoadjuvant Chemotherapy in Esophageal Adenocarcinoma 2023 ·Cancer Research ·Giuseppina Arbore, Luca Albarello, Gabriele Bucci, Marco Punta, Andrea Cossu, Lorella Fanti, (unknown), F. Mauro, (unknown), Gianluigi Arrigoni, Silvia Bonfiglio, (unknown), Francesco Puccetti, Ugo Elmore, Luca Vago, Stefano Cascinu, Giovanni Tonon, Riccardo Rosati, Giulia Casorati, Paolo Dellabona	10
6	Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects 2023 ·Nature Communications ·Salvatore Cortellino, Vincenzo Quagliariello, Gloria Delfanti, Olga Blaževitš, Claudia Chiodoni, Nicola Maurea, Annabella Di Mauro, Fabiana Tatangelo, Federica Pisati, (unknown), Stefano Lazzeri, V. Spagnolo, (unknown), Claudio Tripodo, Giulia Casorati, Paolo Dellabona, Valter D. Longo	36
7	Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 2022 ·Life Science Alliance ·(unknown), Gianluca Rotta, Francesca Clemente, Maya Fedeli, (unknown), Francesco Manfredi, (unknown), Achille Anselmo, Federica Pedica, Guido Fiorentini, (unknown), Maria Pia Protti, Claudio Doglioni, Luca Aldrighetti, Chiara Bonini, Giulia Casorati, Paolo Dellabona, Claudia de Lalla	2
8	TCR-engineered iNKT cells induce robust antitumor response by dual targeting cancer and suppressive myeloid cells 2022 ·Science Immunology ·Gloria Delfanti, Filippo Cortesi, (unknown), (unknown), Laura Azzimonti, Claudia de Lalla, C Garavaglia, Mario Leonardo Squadrito, Maya Fedeli, (unknown), Silvia Sesana, Francesca Re, Haifa Shen, Paolo Dellabona, Giulia Casorati	36
9	Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR‐engineered T cells 2021 ·European Journal of Immunology ·Francesco Manfredi, (unknown), Beatrice Claudia Cianciotti, (unknown), (unknown), Eliana Ruggiero, Zulma Magnani, (unknown), Matteo Doglio, Maddalena Noviello, Elena Tassi, Chiara Balestrieri, (unknown), Francesca Clemente, Claudia de Lalla, Maria Pia Protti, Anna Mondino, Giulia Casorati, Paolo Dellabona, Chiara Bonini	5
10	Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia 2021 ·Nature Communications ·(unknown), C Garavaglia, Andrea Grilli, Claudia de Lalla, Alessandra Mancino, Lucia Mori, Gennaro De Libero, Daniela Montagna, Monica Casucci, Marta Serafini, Chiara Bonini, Daniel Häußinger, Fabio Ciceri, Massimo Bernardi, Sara Mastaglio, Silvio Bicciato, Paolo Dellabona, Giulia Casorati	7
11	Invariant NKT cells contribute to chronic lymphocytic leukemia surveillance and prognosis 2017 ·Blood ·Francesca Gorini, Laura Azzimonti, Gloria Delfanti, Lydia Scarfò, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, Pamela Ranghetti, Alessandro Gulino, Claudio Doglioni, Arianna Di Napoli, Miriam Capri, Claudio Franceschi, Federico Caligaris‐Cappio, Paolo Ghia, Matteo Bellone, Paolo Dellabona, Giulia Casorati, Claudia de Lalla	63
12	Of self‐lipids, CD1‐restricted T cells, and contact sensitization 2017 ·European Journal of Immunology ·Giulia Casorati, Paolo Dellabona	1
13	Invariant NKT cells sustain specific B cell responses and memory 2007 ·Proceedings of the National Academy of Sciences ·Grazia Galli, Paola Pittoni, Elena Tonti, Carmine Malzone, Yasushi Uematsu, Marco Tortoli, Domenico Maione, Gianfranco Volpini, Oretta Finco, Sandra Nuti, Simona Tavarini, Paolo Dellabona, Rino Rappuoli, Giulia Casorati, Sergio Abrignani	189
14	Cutting Edge: Influence of the TCR Vβ Domain on the Selection of Semi-Invariant NKT Cells by Endogenous Ligands 2006 ·The Journal of Immunology ·Jens Schümann, Marcin P. Mycko, Paolo Dellabona, Giulia Casorati, H. Robson MacDonald	64
15	Up-Regulation of CD1d Expression Restores the Immunoregulatory Function of NKT Cells and Prevents Autoimmune Diabetes in Nonobese Diabetic Mice 2004 ·The Journal of Immunology ·Marika Falcone, Federica Facciotti, Nadia Ghidoli, Paolo Monti, Stefano Olivieri, (unknown), Ezio Bonifacio, Giulia Casorati, Francesca Sanvito, Nora Sarvetnick	85
16	Production of Profibrotic Cytokines by Invariant NKT Cells Characterizes Cirrhosis Progression in Chronic Viral Hepatitis 2004 ·The Journal of Immunology ·Claudia de Lalla, Grazia Galli, Luca Aldrighetti, R. Romeo, (unknown), Antonella Monno, Sandra Nuti, Massimo Colombo, Francesco Callea, Steven A. Porcelli, Paola Panina‐Bordignon, Sergio Abrignani, Giulia Casorati, Paolo Dellabona	121
17	Relevance of the Tumor Antigen in the Validation of Three Vaccination Strategies for Melanoma 2000 ·The Journal of Immunology ·Matteo Bellone, Daniela Cantarella, Paola Castiglioni, Mariacristina Crosti, Anna Ronchetti, Monica Moro, Maria Paola Garancini, Giulia Casorati, Paolo Dellabona	111
18	Vaccination with Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity 2000 ·The Journal of Immunology ·Alfonso Martin‐Fontecha, Monica Moro, Mariacristina Crosti, Fabrizio Veglia, Giulia Casorati, Paolo Dellabona	21
19	Tumor cell targeting with antibody-avidin complexes and biotinylated tumor necrosis factor alpha. 1997 ·PubMed ·Monica Moro, Micaela Pelagi, Giulia Fulci, Giovanni Paganelli, Paolo Dellabona, Giulia Casorati, A. G. Siccardi, Angelo Corti	64
20	Molecular approaches to cancer immunotherapy. 1995 ·PubMed ·G Forni, Federica Cavallo, M Consalvo, Alessandra Allione, Paolo Dellabona, Giulia Casorati, Mirella Giovarelli	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact